Tectonic Therapeutic | AVRO - Assets


Tectonic Therapeutic reported $277M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Akebia Therapeutics USD 376.56M 12.41M Dec/2025
Alnylam Pharmaceuticals USD 4.97B 114.67M Dec/2025
Celltrion KRW 21.08T 530.63B Sep/2025
Cspc Pharmaceutical CNY 46B 1.61B Jun/2025
Deva Holding AS TRY 12.93B 1.83B Sep/2023
Dianthus Therapeutics USD 530.92M 46.52M Dec/2025
Divis Laboratories Ltd INR 181.51B 12.19B Sep/2025
Gilead Sciences USD 59.02B 490M Dec/2025
Ionis Pharmaceuticals USD 3.52B 490.91M Dec/2025
Kangmei Pharma CNY 13.68B 38.19M Sep/2025
Karyopharm Therapeutics USD 96.23M 8.65M Sep/2025
Knight Therapeutics CAD 1.05B 10.63M Sep/2025
MacroGenics USD 270.76M 25.34M Sep/2025
Malin Corporation EUR 198.5M 70.1M Dec/2024
Medical Developments International AUD 63.57M 2.83M Dec/2025
Neuren Pharmaceuticals AUD 342.86M 11.61M Dec/2025
Organigram Holdings CAD 562.21M 2.4M Sep/2025
Ovoca Bio EUR 11.41M 3.36M Jun/2022
Pfizer USD 208.73B 2.64B Sep/2025
Pharma Mar EUR 395.08M 53.42M Dec/2025
Qiagen NV USD 6.3B 257.54M Dec/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sangamo BioSciences USD 97.56M 11.39M Jun/2025
Sanofi EUR 126.81B 2.99B Dec/2025
Sarepta Therapeutics USD 3.35B 143.73M Dec/2025
Sartorius EUR 9.61B 413.4M Sep/2025
Sino Biopharmaceutical CNY 74.89B 9.49B Jun/2025
Takeda JPY 15.41T 938.47B Dec/2025
Tilray USD 2.07B 1.33B Mar/2025
Zz Pientze Pharmaceu CNY 17.48B 1.23B Sep/2025